EoECPH - Pharmaceutical Wholesale Services

Tender description

The Pharmaceutical Wholesale Services market continues to grow with new products becoming available and increasing demand with more patients being treated each year. The market can be categorised into contracted lines, agency lines and non-contract lines eligible for discount, the focal point of the commercial element of this framework agreement. With certain products only made available through specified pharmaceutical wholesalers, trusts typically have arrangements with all four of the major players in the market in order to access all products they require. This new framework agreement utilises the national service specification for pharmaceutical wholesale services and the national key performance indicators. The scope of the agreement remains fundamentally unchanged from the outgoing framework with a selection of refinements based on learnings over the previous framework period This framework agreement is for the provision of safe, legal, efficient and cost-effective pharmaceutical wholesale services comprising the delivery of medicines and other pharmaceutical products to Participating Authorities. The scope includes a requirement for the suppliers to work with Trusts, where reasonable and practicable, to meet the needs of the changing landscape such as seven day working or projects which integrate clinical pharmacy services and support risk avoidance and clinical governance agendas. The framework agreement is intended to be available to any Nationally publicly funded entities subject to completion of the framework access agreement. This is a re-tender of an existing framework agreement to ensure continuity of access to Pharmaceutical Wholesale services. The current EoECPH framework is accessed by member Trusts in 4 regions of the UK; East of England(EoE), NHS Commercial Solutions (NHSCS), Thames Valley and Wessex (TVW) and Peninsula Purchasing & Supply Alliance (PPSA) including Ambulance Services in England.